Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


1 Am J Gastroenterol
2 Am J Pathol
3 Biochem Biophys Res Commun
1 BMC Gastroenterol
3 Endoscopy
1 Eur Radiol
2 Gastroenterology
3 Hepatology
2 J Gastroenterol
2 J Gastroenterol Hepatol
2 J Hepatol
3 J Pediatr
1 J Pediatr Surg
2 Lancet
2 Lancet Gastroenterol Hepatol
2 Oncogene
3 PLoS One
3 Transplantation

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Gastroenterol

    Anticoagulation for Portal Vein Thrombosis in Cirrhosis.
    Am J Gastroenterol. 2019 Feb 14. doi: 10.14309/ajg.0000000000000158.
    PubMed     Text format    

    Am J Pathol

  2. MIN Q, Molina L, Li J, Adebayo Michael AO, et al
    beta-Catenin and yes-associated protein 1 cooperate in hepatoblastoma pathogenesis.
    Am J Pathol. 2019 Feb 19. pii: S0002-9440(18)30759.
    PubMed     Text format     Abstract available

  3. ZHANG J, Liu P, Tao J, Wang P, et al
    TEA domain transcription factor 4 (TEAD4) is the major mediator of Yap oncogenic activity in mouse and human hepatoblastoma.
    Am J Pathol. 2019 Feb 19. pii: S0002-9440(18)30776.
    PubMed     Text format     Abstract available

    Biochem Biophys Res Commun

  4. YOSHIMURA S, Nakashima S, Tomiga Y, Kawakami S, et al
    Corrigendum to "Short- and long-term effects of high-fat diet feeding and voluntary exercise on hepatic lipid metabolism in mice" [Biochem. Biophys. Res. Commun. 507 (2018) 291-296].
    Biochem Biophys Res Commun. 2019 Feb 15. pii: S0006-291X(19)30246.
    PubMed     Text format    

  5. LAI C, Gao J, Zhu Z, Yuan J, et al
    DNA methyltransferase expression and DNA hypomethylation status in human hepatocytes following trichloroacetic acid exposure.
    Biochem Biophys Res Commun. 2019 Feb 16. pii: S0006-291X(19)30198.
    PubMed     Text format     Abstract available

  6. HAN X, Hong Y, Zhang K
    TUG1 is involved in liver fibrosis and activation of HSCs by regulating miR-29b.
    Biochem Biophys Res Commun. 2018;503:1394-1400.
    PubMed     Text format     Abstract available

    BMC Gastroenterol

  7. ZHENG J, Zhang Y, Li P, Zhang S, et al
    The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study.
    BMC Gastroenterol. 2019;19:32.
    PubMed     Text format     Abstract available


  8. DEDANIA B, Kukreja K, Davee T, Bhutani MS, et al
    Endoscopic ultrasound-guided sclerosant injection and coil embolization of bleeding gastric varices.
    Endoscopy. 2018;50:283-285.
    PubMed     Text format    

  9. MUTIGNANI M, Forti E, Tringali A, Cintolo M, et al
    Lumen-apposing metal stent for pediatric use: report of a challenging case.
    Endoscopy. 2018;50:E57-E58.
    PubMed     Text format    

  10. ISHIWATARI H, Satoh T, Sato J, Fujie S, et al
    Bent needle technique as a rescue for bile duct puncture in endoscopic ultrasonography-guided intrahepatic biliary drainage.
    Endoscopy. 2019 Feb 21. doi: 10.1055/a-0835-5843.
    PubMed     Text format    

    Eur Radiol

  11. KIM MJ, Lee S, An C
    Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma.
    Eur Radiol. 2019 Feb 20. pii: 10.1007/s00330-019-06030.
    PubMed     Text format     Abstract available


  12. BRUIX J, Ayuso C
    Diagnosis of Hepatic Nodules in Patients at Risk for Hepatocellular Carcinoma: LI-RADS Probability Versus Certainty.
    Gastroenterology. 2019 Feb 15. pii: S0016-5085(19)30381.
    PubMed     Text format    

    The Changing Scenario of Screening and Surveillance of Esophageal Varices.
    Gastroenterology. 2019 Feb 15. pii: S0016-5085(19)30384.
    PubMed     Text format    


  14. MEHAL WZ, Loomba R
    The Intestinal Microbiome, Plasma Metabolome and Liver Transcriptome- A Conspiracy Driving Hepatic Steatosis.
    Hepatology. 2019 Feb 19. doi: 10.1002/hep.30577.
    PubMed     Text format     Abstract available

  15. MATAK A, Lahiri P, Ford E, Pabst D, et al
    Stochastic phenotype switching leads to intratumor heterogeneity in human liver cancer.
    Hepatology. 2018;68:933-948.
    PubMed     Text format     Abstract available

  16. KAPURIA D, Ben-Yakov G, Ortolano R, Ho-Cho M, et al
    The Spectrum of Hepatic Involvement in Patients with Telomere Disease.
    Hepatology. 2019 Feb 21. doi: 10.1002/hep.30578.
    PubMed     Text format     Abstract available

    J Gastroenterol

  17. TSUSHIMA K, Tsuge M, Hiraga N, Uchida T, et al
    Comparison of intracellular responses between HBV genotype A and C infection in human hepatocyte chimeric mice.
    J Gastroenterol. 2019 Feb 21. pii: 10.1007/s00535-019-01558.
    PubMed     Text format     Abstract available

  18. KOBAYASHI M, Kudo M, Izumi N, Kaneko S, et al
    Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan.
    J Gastroenterol. 2019 Feb 20. pii: 10.1007/s00535-019-01554.
    PubMed     Text format     Abstract available

    J Gastroenterol Hepatol

  19. MAK LY, Ko M, To E, Wong DK, et al
    Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients.
    J Gastroenterol Hepatol. 2019 Feb 20. doi: 10.1111/jgh.14637.
    PubMed     Text format     Abstract available

  20. HANAI T, Shiraki M, Watanabe S, Imai K, et al
    Prognostic significance of minimal hepatic encephalopathy in patients with liver cirrhosis in Japan: a propensity score-matching analysis.
    J Gastroenterol Hepatol. 2019 Feb 18. doi: 10.1111/jgh.14635.
    PubMed     Text format     Abstract available

    J Hepatol

  21. SINGH SP, Panigrahi S, Mishra D, Khatua CR, et al
    Alcohol-associated liver disease, not hepatitis B, is the major cause of cirrhosis in Asia.
    J Hepatol. 2019 Feb 16. pii: S0168-8278(19)30012.
    PubMed     Text format    

  22. MANCO R, Clerbaux LA, Verhulst S, Nader MB, et al
    Reactive cholangiocytes differentiate into proliferative hepatocytes with efficient DNA repair in mice with chronic liver injury.
    J Hepatol. 2019 Feb 19. pii: S0168-8278(19)30117.
    PubMed     Text format     Abstract available

    J Pediatr

  23. SUNDARAM SS, Halbower AC, Klawitter J, Pan Z, et al
    Treating Obstructive Sleep Apnea and Chronic Intermittent Hypoxia Improves the Severity of Nonalcoholic Fatty Liver Disease in Children.
    J Pediatr. 2018;198:67-75.
    PubMed     Text format     Abstract available

  24. LEE CK, Mitchell PD, Raza R, Harney S, et al
    Validation of Transient Elastography Cut Points to Assess Advanced Liver Fibrosis in Children and Young Adults: The Boston Children's Hospital Experience.
    J Pediatr. 2018;198:84-89.
    PubMed     Text format     Abstract available

  25. HARLOW KE, Africa JA, Wells A, Belt PH, et al
    Clinically Actionable Hypercholesterolemia and Hypertriglyceridemia in Children with Nonalcoholic Fatty Liver Disease.
    J Pediatr. 2018;198:76-83.
    PubMed     Text format     Abstract available

    J Pediatr Surg

  26. LEMOINE C, Lokar J, McColley SA, Alonso EM, et al
    Cystic fibrosis and portal hypertension: Distal splenorenal shunt can prevent the need for future liver transplant.
    J Pediatr Surg. 2019 Feb 2. pii: S0022-3468(19)30072.
    PubMed     Text format     Abstract available


  27. OVADIA C, Seed PT, Sklavounos A, Geenes V, et al
    Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
    Lancet. 2019 Feb 14. pii: S0140-6736(18)31877.
    PubMed     Text format     Abstract available

  28. PALMER KR, Xiaohua L, Mol BW
    Management of intrahepatic cholestasis in pregnancy.
    Lancet. 2019 Feb 14. pii: S0140-6736(18)32323.
    PubMed     Text format    

    Lancet Gastroenterol Hepatol

    Ensuring timely treatment of patients with primary biliary cholangitis.
    Lancet Gastroenterol Hepatol. 2018 Jul 12. pii: S2468-1253(18)30177.
    PubMed     Text format    

  30. POSE E, Gines P
    Transient elastography for alcoholic liver disease: a step forward.
    Lancet Gastroenterol Hepatol. 2018 Jul 5. pii: S2468-1253(18)30212.
    PubMed     Text format    


  31. YOON S, Lee EJ, Choi JH, Chung T, et al
    Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer.
    Oncogene. 2018;37:4443-4454.
    PubMed     Text format     Abstract available

  32. ZHAO Y, Hu X, Wei L, Song D, et al
    PARP10 suppresses tumor metastasis through regulation of Aurora A activity.
    Oncogene. 2018;37:2921-2935.
    PubMed     Text format     Abstract available

    PLoS One

  33. KIMER N, Gudmann NS, Pedersen JS, Moller S, et al
    No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial.
    PLoS One. 2018;13:e0203200.
    PubMed     Text format     Abstract available

  34. HARRISON SA, Dennis A, Fiore MM, Kelly MD, et al
    Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial.
    PLoS One. 2018;13:e0203054.
    PubMed     Text format     Abstract available

  35. FRANSEN PETTERSSON N, Deronic A, Nilsson J, Hannibal TD, et al
    The immunomodulatory quinoline-3-carboxamide paquinimod reverses established fibrosis in a novel mouse model for liver fibrosis.
    PLoS One. 2018;13:e0203228.
    PubMed     Text format     Abstract available


  36. LEE KW, Han S, Lee S, Cha HH, et al
    Higher Risk of Posttransplant Liver Graft Failure in Male Recipients of Female Donor Grafts Might Not Be Due to Anastomotic Size Disparity.
    Transplantation. 2018;102:1115-1123.
    PubMed     Text format     Abstract available

  37. CROOME KP, Mathur AK, Lee DD, Moss AA, et al
    Outcomes of Donation After Circulatory Death Liver Grafts From Donors 50 Years or Older: A Multicenter Analysis.
    Transplantation. 2018;102:1108-1114.
    PubMed     Text format     Abstract available

  38. VANWAGNER LB, Montag S, Zhao L, Allen NB, et al
    Cardiovascular Disease Outcomes Related to Early Stage Renal Impairment Following Liver Transplantation.
    Transplantation. 2018 Mar 20. doi: 10.1097/TP.0000000000002175.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.